Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00135876
Status:
COMPLETED
Last Update Posted:
2007-04-27
First Post:
2005-08-24
Brief Title:
Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients
Sponsor:
Ontario Clinical Oncology Group OCOG
Organization:
Ontario Clinical Oncology Group OCOG
Organization Data
Organization:
Ontario Clinical Oncology Group OCOG
Class:
OTHER
Study ID:
524E-CVD-0056-013
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ontario Clinical Oncology Group OCOG
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Pfizer | INDUSTRY |